Proteome Sciences Share Discussion Threads

[peverill] 10/10/2024 04:24

The execution was probably based on the company being taken over by people who actually knew what they were doing,rather than a gang of sheisters chasing rainbows and barking up the wrong tree for 30 years,but were too stubborn to change direction.

[goatherd] 09/10/2024 17:06

I was working from "facts" published by Proteome which turned out to be grossly inaccurate.

and the very word "guesstimate" was intended to show that guesswork was involved.

Funnily enough I still refer to some of them; and are pleased with their accuracy, although they were perhaps a touch on the low side.

It was execution which was wrong! And I caveated about that in every single guesstimate.

[jeffian] 09/10/2024 17:02

My point being, Richard, that the PRM threads have produced literally hundreds of thousands of posts based on the hypotheses of posters, almost all of which turned out to be wide of the mark

[monte1] 09/10/2024 16:45

So, in summary, the avatar could not accurately estimate the price reached and the time taken to reach it. Upper guesstimate, iirc, £53 and current price is three pence. Potential time to reach said lofty guesstimate 1yr, 5yr or even 10 - guesstimates made at least 15 years ago.
I am no expert on these things but it seems like the avatar may have been a bit off in his thinking.

[goatherd] 09/10/2024 15:54

Well, I am not sure even of that now. :-(

[dominiccummings] 09/10/2024 15:45

Aye. To be fair Jeffian, Goatherd has said (thousands of times) that he could not accurately estimate the time it would take for PRM shares to be £8.

But rest assured, they will, one fine day.

[goatherd] 09/10/2024 15:32

Thank you, Jeffian, for confirming what I have always thought.

That you did not understand the purpose, methodology or aims of my "guesstimates".

Though, heaven knows, I have said it often enough.

[barry evans] 09/10/2024 14:53

Avatars cant account for phone lines being down in Ireland, jeffian.

[jeffian] 09/10/2024 14:51

Life actually is simple if you stick to the facts and what you are told via verifiable account and RNS statements without adding one's own 'interpretations' and 'reading between the lines' leading to 'guesstimates'.

[goatherd] 09/10/2024 14:31

I don't think so elpirita!

I originally thought Proteome would invent, develop and market its own products.

But that was in the days when pretty much everyone thought that
one biomarker = one disease

If only life was so simple!

[elpirata] 09/10/2024 14:10

goatherd has a chronic case of

[dominiccummings] 09/10/2024 13:33

So far peverill, so far. Goatherd still has high hopes of a rapid rise when the markets discover that their paths to commercial success are blocked by our healthy patents.

[peverill] 09/10/2024 06:20

Basket case.spent years amassing bio markers and technology no one needs.Brilliant business model.

[elpirata] 08/10/2024 08:47

prm mcap £9m at 3p mid

cjp loan at 30 June £11,678,000

quite remarkable

[peverill] 08/10/2024 08:03

What if they don't?????????

[elpirata] 07/10/2024 22:15

Diggle has done his conkers on this & obd. His 68m prm shares are now worth a measly £2m while his 30m obd shares which were worth £12m this time last year are now worth £1m

[dominiccummings] 07/10/2024 20:54

I would be absolutely amazed if either were prepared to throw more cash into this pit.

[monte1] 07/10/2024 20:33

Pie in the sky.

[goatherd] 07/10/2024 20:28

Despite the last two posts, I think PRM could be funded by either CJP, or Vulpes, or both.

And, anyway, if there is a clear case, most companies will settle.

[barry evans] 07/10/2024 20:00

I note that the idiotic 93121 has 4 upticks whereas the factchecking 93122 has none to this point.

[elpirata] 07/10/2024 18:33

Exactly who do you think would have the time and technical capacity to police biomarker patents, prm doesnt even have in house counsel, theres only Pike & Dennis left.

As for finance, youre kidding

AI Overview

United Kingdom
In the Patents Court, costs typically start at £1 million and can escalate to £1.5–2 million for small to medium-sized disputes...

Biotech patent litigation can cost around $2.5 million per case, on average. The high cost is due to the complex technologies involved in biotechnology, which require technical analysis and expert witnesses...

During the year 2020, US courts awarded $4.67 billion in patent damages. Patent litigation costs between $2.3 million and $4 million on average. It takes one to three years for a patent case to reach trial.

[goatherd] 06/10/2024 15:58

They are waiting for someone else to use biomarkers for which they hold patents.

And there are a LOT of these!

Given they do not have funds to develop themselves I believe it to be sound tactics.

Although I think they have adequate finance to pursue patent claims; and to keep patents current.

[elpirata] 06/10/2024 11:22

'Game changer' blood test detects 12 most common cancers before symptoms develop



Southampton Uni spin off Xgenera Ltd, £2.5m govt funding, test cost £120 & expected NHS adoption in 5 - 7 years

Its part of this;



The winners of the £11 million NIHR i4i Early Cancer Diagnosis Clinical Validation and Evaluation funding call are:

Dr Andrew Shapanis, Professor Paul Skipp, XGENERA Ltd
miONCO-Dx: A novel multi cancer early diagnostic test
Improving the efficiency and evaluating the performance of a new cancer blood test for use as a screening tool.

PRM nowhere to be seen of course, what are they doing?

[sandcrab2] 05/10/2024 13:37

I note that the excellent Goatherd has now turned bullish on PREM

The bell for the bottom there has now rung

BUY MORTIMER BUY!!

[elpirata] 04/10/2024 11:46

much more appropriate to prm lth's

The global electric wheelchair market is projected to grow at a CAGR of 11.5% between 2024 and 2032.

To know more, visit :-

Key players are :- Graham-Field
Karman Healthcare
Kymco Healthcare